Breaking out of the top of the Bollinger bar. Still in ASX 300, SBM must be too pricey for some funds
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025